Archive | Cancer in the News

Melanoma Journal Articles for January 2018

Ophthalmology Conjunctival amelanotic malignant melanoma arising in primary acquired melanosis sine pigmento MD Venita Jay and MD Ramon L. Font https://doi.org/10.1016/S0161-6420(98)92156-X Annals of Surgical Oncology Melanoma Surveillance Strategies: Different Approaches to a Shared Goal Keisuke Shirai and Sandra L. Wong First Online: 02 January 2018 DOI https://doi.org/10.1245/s10434-017-6321-5 The New England Journal of Medicine Management of Sentinel-Node Metastasis in Melanoma Lisa […]

Read the full story

Posted in Journal Articles

Nivolumab Earns FDA Approval as Adjuvant Therapy for Melanoma Based on Checkmate-238 Trial

According to the National Cancer Institute, about 2.2% of people will be diagnosed with melanoma at a point in their lifetime.

Read the full story

Posted in Melanoma In The News, European Approval

Ipilimumab Approaches EU Approval for Pediatric Melanoma

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of ipilimumab (Yervoy) for the treatment of pediatric patients aged 12 years and older with unresectable or metastatic melanoma, according to Bristol-Myers Squibb (BMS), the manufacturer of the CTLA-4 inhibitor.

Read the full story

Posted in Melanoma In The News, European Approval

EMA’s CHMP Recommends Yervoy for Patients 12 and Older with Advanced Melanoma

Yervoy (ipilimumab) has received a positive review by the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP), recommending its approval for the treatment of unresectable or metastatic melanoma in patients age 12 and older.

Read the full story

Posted in Melanoma In The News, European Approval

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories